These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23485763)

  • 21. [Hyperhaplotypes of A, B and DR loci of HLA region in patients with recurrent aphthous ulceration].
    Albanidou-Farmaki E; Kayavis I; Polymenidis Z; Papanayotou P
    Hell Stomatol Chron; 1990; 34(1):17-20. PubMed ID: 2130029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia.
    Lennikov A; Alekberova Z; Goloeva R; Kitaichi N; Denisov L; Namba K; Takeno M; Ishigatsubo Y; Mizuki N; Nasonov E; Ishida S; Ohno S
    Clin Rheumatol; 2015 Feb; 34(2):321-7. PubMed ID: 24322831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS).
    Freysdottir J; Lau S; Fortune F
    Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales.
    Darke C; Guttridge MG; Thompson J; McNamara S; Street J; Thomas M
    Exp Clin Immunogenet; 1998; 15(2):69-83. PubMed ID: 9691201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
    Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
    Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on association between polymorphism of HLA-DRB1 alleles and Behçet's disease.
    Shang YB; Zhai N; Li JP; Han SX; Ren QS; Song FJ; Chen HD
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1419-22. PubMed ID: 20205319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of HLA-B*51:01 and -A*26:01 to Behçet's disease and their clinical association in Thai patients.
    Louthrenoo W; Kasitanon N; Pathanapitoon K; Wangkaew S; Kuwata S; Nishi A; Kaburaki T; Tanaka R; Takeuchi F
    Int J Rheum Dis; 2020 Feb; 23(2):247-255. PubMed ID: 31944588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
    Aridogan BC; Yildirim M; Baysal V; Inaloz HS; Baz K; Kaya S
    J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possibility of a viral etiology in recurrent aphthous ulcers and Behçet's syndrome.
    Hooks JJ
    J Oral Pathol; 1978; 7(6):353-64. PubMed ID: 105094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behçet's disease and major histocompatibility complex class II antigens in Tunisians.
    Hamza M; Ayed K; Hamzaoui K; Bardi R
    Dis Markers; 1988; 6(4):263-7. PubMed ID: 3233881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric parietal cell and thyroid autoantibodies in patients with Behcet's disease.
    Lin HP; Wu YH; Yu-Fong Chang J; Wang YP; Chen HM; Sun A
    J Formos Med Assoc; 2018 Jun; 117(6):505-511. PubMed ID: 29549982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of HLA-B5 antigen with specific manifestations of Behçet's disease.
    Azizleri G; Aksungur VL; Sarica R; Akyol E; Ovül C
    Dermatology; 1994; 188(4):293-5. PubMed ID: 8193403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine levels in patients with Behçet's disease and patients with recurrent aphthous stomatitis.
    Gönül M; Gül U; Kilinç C; Cakmak SK; Soylu S; Kiliç A
    Clin Rheumatol; 2009 Oct; 28(10):1153-6. PubMed ID: 19575262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-18 gene polymorphisms in aphthous stomatitis vs. Behçet's disease in a cohort of Egyptian patients.
    Hazzaa HH; Rashwan WA; Attia EA
    J Oral Pathol Med; 2014 Nov; 43(10):746-53. PubMed ID: 24935632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAP polymorphism in patients with Behçet's disease.
    González-Escribano MF; Morales J; García-Lozano JR; Castillo MJ; Sánchez-Román J; Núñez-Roldán A; Sánchez B
    Ann Rheum Dis; 1995 May; 54(5):386-8. PubMed ID: 7794046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease.
    Kaya TI; Dur H; Tursen U; Gurler A
    Clin Exp Dermatol; 2002 Sep; 27(6):498-501. PubMed ID: 12372094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Behcet's syndrome in patients with recurrent aphthous ulcerations in Brazil.
    Tunes RS; Anjos TC; Martins GB; Barreto ER; Santiago MB
    Rheumatol Int; 2009 Jun; 29(8):875-8. PubMed ID: 19037605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Close association of HLA-B51 in persons with recurrent aphthous stomatitis.
    Shohat-Zabarski R; Kalderon S; Klein T; Weinberger A
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):455-8. PubMed ID: 1408019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-antigens in black patients with hepatocellular carcinoma.
    Maharaj B; Khedun SM; Hammond MG
    East Afr Med J; 1997 Nov; 74(11):705-7. PubMed ID: 9557441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral mucosal antigen reactivity during exacerbation and remission phases of recurrent aphthous ulceration.
    Lindemann RA; Riviere GR; Sapp JP
    Oral Surg Oral Med Oral Pathol; 1985 Sep; 60(3):281-4. PubMed ID: 3862041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.